BCL-2 antisense and cisplatin combination treatment of MCF-7 breast cancer cells with or without functional p53
β Scribed by Hesham Basma; Hesham El-Refaey; Magdalene K. Sgagias; Kenneth H. Cowan; Xu Luo; Pi-Wan Cheng
- Publisher
- BioMed Central
- Year
- 2005
- Tongue
- English
- Weight
- 419 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1021-7770
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recent studies have shown that high levels of the apoptosisrelated proteins bcl-2 and bcl-x, increase, while over-expression of bcl-x, or bax decreases, resistance to drugs that induce apoptosis in some human cancer cells. In the present report, we investigated whether expression of these apoptosis-
## Abstract The original article to which this Erratum refers was published in International Journal of Cancer (2005) 115(1) 74β84 DOI: 10.1002/ijc.20856
Derivatives of camptothecins, topoisomerase I inhibitors and 7-hydroxystaurosporine (UCN-01), a protein kinase C (PKC) inhibitor and cell cycle checkpoint abrogator, are promising anticancer drugs. We characterized the apoptotic response to camptothecin and UCN-01 for the 8 human breast carcinoma ce